Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption

Viral reservoirs are involved in persistent HIV infection, and a small number of mosaic latent cellular reservoirs promote viral rebound upon analytical treatment interruption, which is the major obstacle to a cure. However, early indicators that can predict resurgence of viremia after treatment interruption may aid treatment decisions in people living with HIV. ABSTRACT The human immunodeficiency virus (HIV) reservoir is responsible for persistent viral infection, and a small number of mosaic latent cellular reservoirs promote viral rebound upon antiretroviral therapy interruption, which is the major obstacle to a cure. However, markers that determine effective therapy and viral rebound posttreatment interruption remain unclear. In this study, we comprehensively and longitudinally tracked dynamic decay of cell-associated viral RNA/DNA in systemic and lymphoid tissues in simian immunodeficiency virus (SIV)-infected rhesus macaques on prolonged combined antiretroviral therapy (cART) and evaluated predictors of viral rebound after treatment cessation. The results showed that suppressive ART substantially reduced plasma SIV RNA, cell-associated unspliced, and multiply spliced SIV RNA to undetectable levels, yet viral DNA remained detectable in systemic tissues and lymphoid compartments throughout cART. Intriguingly, a rapid increase of integrated proviral DNA in peripheral mononuclear cells was detected once treatment was withdrawn, accompanied by the emergence of detectable plasma viral load. Notably, the increase of peripheral proviral DNA after treatment interruption correlated with the emergence and degree of viral rebound. These findings suggest that measuring total viral DNA in SIV infection may be a relatively simple surrogate marker of reservoir size and may predict viral rebound after treatment interruption and inform treatment strategies. IMPORTANCE Viral reservoirs are involved in persistent HIV infection, and a small number of mosaic latent cellular reservoirs promote viral rebound upon analytical treatment interruption, which is the major obstacle to a cure. However, early indicators that can predict resurgence of viremia after treatment interruption may aid treatment decisions in people living with HIV. Utilizing the rhesus macaque model, we demonstrated that increased proviral DNA in peripheral cells after treatment interruption, rather than levels of proviral DNA, was a useful marker to predict the emergence and degree of viral rebound after treatment interruption, providing a rapid approach for monitoring HIV rebound and informing decisions.

[1]  R. Siliciano,et al.  Recommendations for measuring HIV reservoir size in cure-directed clinical trials , 2020, Nature medicine.

[2]  R. Siliciano,et al.  Recommendations for measuring HIV reservoir size in cure-directed clinical trials , 2020, Nature Medicine.

[3]  R. Siliciano,et al.  A unique viral reservoir landscape in HIV-1 elite controllers , 2020, Nature.

[4]  Richard D Moore,et al.  Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy. , 2020, The Journal of clinical investigation.

[5]  R. Siliciano,et al.  Different human resting memory CD4+ T cell subsets show similar low inducibility of latent HIV-1 proviruses , 2020, Science Translational Medicine.

[6]  Runxia Liu,et al.  The forces driving clonal expansion of the HIV-1 latent reservoir , 2020, Virology Journal.

[7]  D. Margolis,et al.  New Frontiers in Measuring and Characterizing the HIV Reservoir , 2019, Front. Microbiol..

[8]  D. Kuritzkes,et al.  Early antiretroviral therapy in neonates with HIV-1 infection restricts viral reservoir size and induces a distinct innate immune profile , 2019, Science Translational Medicine.

[9]  J. Lifson,et al.  Predictors of SIV recrudescence following antiretroviral treatment interruption , 2019, eLife.

[10]  J. Ananworanich,et al.  Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy , 2019, Journal of Virology.

[11]  S. Hughes,et al.  HIV Infected T Cells Can Proliferate in vivo Without Inducing Expression of the Integrated Provirus , 2019, Front. Microbiol..

[12]  K. Maeda,et al.  HIV-1 DNA-capture-seq is a useful tool for the comprehensive characterization of HIV-1 provirus , 2019, Scientific Reports.

[13]  K. Metzner,et al.  Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART , 2019, Nature Communications.

[14]  A. Das,et al.  On the generation of the MSD-Ѱ class of defective HIV proviruses , 2019, Retrovirology.

[15]  R. Siliciano,et al.  The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections. , 2019, Cell host & microbe.

[16]  S. Hughes,et al.  Clonal expansion of SIV-infected cells in macaques on antiretroviral therapy is similar to that of HIV-infected cells in humans , 2019, PLoS pathogens.

[17]  Michelle E. Wong,et al.  The HIV Reservoir in Monocytes and Macrophages , 2019, Front. Immunol..

[18]  M. Vignuzzi,et al.  Defective viral genomes are key drivers of the virus–host interaction , 2019, Nature Microbiology.

[19]  Taina T. Immonen,et al.  Defining early SIV replication and dissemination dynamics following vaginal transmission , 2019, Science Advances.

[20]  L. Ndhlovu,et al.  Impact of Myeloid Reservoirs in HIV Cure Trials , 2019, Current HIV/AIDS Reports.

[21]  J. Ananworanich,et al.  Impact of Early Antiretroviral Therapy on Detection of Cell-Associated HIV-1 Nucleic Acid in Blood by the Roche Cobas TaqMan Test , 2019, Journal of Clinical Microbiology.

[22]  M. Nonnemacher,et al.  Genetic variation and function of the HIV-1 Tat protein , 2019, Medical Microbiology and Immunology.

[23]  S. Migueles,et al.  Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion , 2019, Nature Communications.

[24]  E. Rosenberg,et al.  Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy , 2019, The Journal of clinical investigation.

[25]  M. Nussenzweig,et al.  Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption , 2018, Proceedings of the National Academy of Sciences.

[26]  F. Maldarelli,et al.  The role of integration and clonal expansion in HIV infection: live long and prosper , 2018, Retrovirology.

[27]  D. Richman,et al.  Improved assays to measure and characterize the inducible HIV reservoir , 2018, EBioMedicine.

[28]  K. Bar,et al.  Lessons learned from HIV antiretroviral treatment interruption trials , 2018, Current opinion in HIV and AIDS.

[29]  M. Lederman,et al.  HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers , 2018, The Journal of clinical investigation.

[30]  L. Picker,et al.  Early antiretroviral therapy limits SIV reservoir establishment to delay or prevent post-treatment viral rebound , 2018, Nature Medicine.

[31]  R. Ribeiro,et al.  Dynamics of Simian Immunodeficiency Virus Two-Long-Terminal-Repeat Circles in the Presence and Absence of CD8+ Cells , 2018, Journal of Virology.

[32]  C. Rouzioux,et al.  Total HIV DNA: a global marker of HIV persistence , 2018, Retrovirology.

[33]  J. Mellors,et al.  Blood biomarkers of expressed and inducible HIV-1 , 2018, AIDS.

[34]  S. Bernacchi,et al.  Retroviral RNA Dimerization: From Structure to Functions , 2018, Front. Microbiol..

[35]  J. Wong,et al.  HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing , 2018, Science Translational Medicine.

[36]  R. Siliciano,et al.  Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir , 2018, Retrovirology.

[37]  D. Kaufmann,et al.  Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs , 2018, Retrovirology.

[38]  Sofie Rutsaert,et al.  Digital PCR as a tool to measure HIV persistence , 2018, Retrovirology.

[39]  B. Berkhout,et al.  What do we measure when we measure cell-associated HIV RNA , 2018, Retrovirology.

[40]  M. Massanella,et al.  Inducible HIV RNA transcription assays to measure HIV persistence: pros and cons of a compromise , 2018, Retrovirology.

[41]  E. Rosenberg,et al.  Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells , 2017, The Journal of clinical investigation.

[42]  R. Siliciano,et al.  HIV persistence: clonal expansion of cells in the latent reservoir. , 2017, The Journal of clinical investigation.

[43]  J. Mellors,et al.  Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART , 2017, Proceedings of the National Academy of Sciences.

[44]  R. Siliciano,et al.  Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. , 2017, Cell host & microbe.

[45]  S. Hughes,et al.  Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir , 2017, PLoS pathogens.

[46]  J. Brenchley,et al.  Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques. , 2017, JCI insight.

[47]  A. Ciuffi,et al.  HIV-1 latent reservoir: size matters , 2016, Future virology.

[48]  G. Silvestri,et al.  Quantifying integrated SIV-DNA by repetitive-sampling Alu-gag PCR , 2016, Journal of virus eradication.

[49]  B. Walker,et al.  Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals. , 2016, Cell host & microbe.

[50]  C. Rouzioux,et al.  Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications , 2016, Clinical Microbiology Reviews.

[51]  R. Dewar,et al.  Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy , 2016, Proceedings of the National Academy of Sciences.

[52]  R. Siliciano,et al.  Defective proviruses rapidly accumulate during acute HIV-1 infection , 2016, Nature Medicine.

[53]  J. Wong,et al.  Tissue reservoirs of HIV , 2016, Current opinion in HIV and AIDS.

[54]  S. Hughes,et al.  What Integration Sites Tell Us about HIV Persistence. , 2016, Cell host & microbe.

[55]  Ellen R. Forsyth,et al.  Quantitation of Productively Infected Monocytes and Macrophages of Simian Immunodeficiency Virus-Infected Macaques , 2016, Journal of Virology.

[56]  S. Lewin,et al.  Paediatric HIV infection: the potential for cure , 2016, Nature Reviews Immunology.

[57]  V. Calvez,et al.  Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir , 2016, AIDS.

[58]  M. Lichterfeld,et al.  Integrated and Total HIV-1 DNA Predict Ex Vivo Viral Outgrowth , 2016, PLoS pathogens.

[59]  D. Richman,et al.  Measuring the latent reservoir in vivo. , 2016, The Journal of clinical investigation.

[60]  J. Mellors,et al.  Novel Assays for Measurement of Total Cell-Associated HIV-1 DNA and RNA , 2016, Journal of Clinical Microbiology.

[61]  J. Church.  B Cell Follicle Sanctuary Permits Persistent Productive Simian Immunodeficiency Virus Infection in Elite Controllers , 2015, Pediatrics.

[62]  A. Lackner,et al.  Persistent Simian Immunodeficiency Virus Infection Drives Differentiation, Aberrant Accumulation, and Latent Infection of Germinal Center Follicular T Helper Cells , 2015, Journal of Virology.

[63]  B. Berkhout,et al.  Minor Contribution of Chimeric Host-HIV Readthrough Transcripts to the Level of HIV Cell-Associated gag RNA , 2015, Journal of Virology.

[64]  F. Maldarelli.  HIV-infected cells are frequently clonally expanded after prolonged antiretroviral therapy: implications for HIV persistence , 2015, Journal of virus eradication.

[65]  D. Hazuda,et al.  A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals , 2015, EBioMedicine.

[66]  A. Haase,et al.  Large number of rebounding/founder HIV variants emerge from multifocal infection in lymphatic tissues after treatment interruption , 2015, Proceedings of the National Academy of Sciences.

[67]  Florian Klein,et al.  HIV-1 Integration Landscape during Latent and Active Infection , 2015, Cell.

[68]  J. R. Williamson.  Really exasperating viral protein from HIV , 2015, eLife.

[69]  M. Carrington,et al.  Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study , 2014, AIDS.

[70]  David Mavor,et al.  RNA-directed remodeling of the HIV-1 protein Rev orchestrates assembly of the Rev–Rev response element complex , 2014, eLife.

[71]  M. Carrington,et al.  HIV-1 DNA predicts disease progression and post-treatment virological control , 2014, eLife.

[72]  Jinyan Liu,et al.  Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys , 2014, Nature.

[73]  P. Messiaen,et al.  Quantification of integrated HIV DNA by repetitive-sampling Alu-HIV PCR on the basis of poisson statistics. , 2014, Clinical chemistry.

[74]  L. Sardo,et al.  Life of psi: how full-length HIV-1 RNAs become packaged genomes in the viral particles. , 2014, Virology.

[75]  Feng Fu,et al.  Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1 , 2014, Proceedings of the National Academy of Sciences.

[76]  Alan S Perelson,et al.  Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.

[77]  Sarah B. Laskey,et al.  Replication-Competent Noninduced Proviruses in the Latent Reservoir Increase Barrier to HIV-1 Cure , 2013, Cell.

[78]  P. Lemey,et al.  Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients Reveals that the Majority of CD4+ T-cells Contain One HIV-1 DNA Molecule , 2013, PLoS pathogens.

[79]  M. Lederman,et al.  Interleukin-7 promotes HIV persistence during antiretroviral therapy. , 2013, Blood.

[80]  B. Berkhout,et al.  Cell-associated HIV RNA: a dynamic biomarker of viral persistence , 2013, Retrovirology.

[81]  K. Stühler,et al.  Tra2-Mediated Recognition of HIV-1 5′ Splice Site D3 as a Key Factor in the Processing of vpr mRNA , 2012, Journal of Virology.

[82]  L. Montaner,et al.  Concurrent measures of total and integrated HIV DNA monitor reservoirs and ongoing replication in eradication trials , 2012, AIDS.

[83]  A. Wargo,et al.  Viral fitness: definitions, measurement, and current insights , 2012, Current Opinion in Virology.

[84]  A. Das,et al.  Upstream AUG Codons in the Simian Immunodeficiency Virus SIVmac239 Genome Regulate Rev and Env Protein Translation , 2012, Journal of Virology.

[85]  Frederic D. Bushman,et al.  Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing , 2012, Nucleic acids research.

[86]  A. Lackner,et al.  IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques , 2012, Mucosal Immunology.

[87]  E. Domingo,et al.  Viral Quasispecies Evolution , 2012, Microbiology and Molecular Reviews.

[88]  Jonathan Karn,et al.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression. , 2012, Cold Spring Harbor perspectives in medicine.

[89]  Wei Shao,et al.  Majority of CD4+ T cells from peripheral blood of HIV-1–infected individuals contain only one HIV DNA molecule , 2011, Proceedings of the National Academy of Sciences.

[90]  Matthew S. Lewis,et al.  Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.

[91]  B. Berkhout,et al.  Cellular Levels of HIV Unspliced RNA from Patients on Combination Antiretroviral Therapy with Undetectable Plasma Viremia Predict the Therapy Outcome , 2009, PloS one.

[92]  Geneviève Boucher,et al.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation , 2009, Nature Medicine.

[93]  T. Chun,et al.  High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections , 2009, Proceedings of the National Academy of Sciences.

[94]  H. Günthard,et al.  Cellular viral rebound after cessation of potent antiretroviral therapy predicted by levels of multiply spliced HIV-1 RNA encoding nef. , 2004, The Journal of infectious diseases.

[95]  T. Perneger,et al.  Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions , 2004, AIDS.

[96]  K. Chatfield,et al.  The use of non-human primates in research and testing , 2002, Animal Welfare.

[97]  M. Malim,et al.  A Sensitive, Quantitative Assay for Human Immunodeficiency Virus Type 1 Integration , 2002, Journal of Virology.

[98]  J. Goedert,et al.  Quantitation of Human Immunodeficiency Virus Type 1 DNA Forms with the Second Template Switch in Peripheral Blood Cells Predicts Disease Progression Independently of Plasma RNA Load , 2002, Journal of Virology.

[99]  H. Günthard,et al.  Residual HIV-RNA levels persist for up to 2.5 years in peripheral blood mononuclear cells of patients on potent antiretroviral therapy. , 2000, AIDS research and human retroviruses.

[100]  Andrew N. Rowan.  Guide for the Care and Use of Laboratory Animals , 1996 .

[101]  D. Purcell,et al.  Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity , 1993, Journal of virology.

[102]  R. Siliciano,et al.  Assays to Measure Latency, Reservoirs, and Reactivation. , 2018, Current topics in microbiology and immunology.

[103]  W. Greene,et al.  Distinct Chromatin Functional States Correlate with HIV 1 Latency Reactivation in Infected Primary CD 4 + T cells 2 3 , 2018 .

[104]  S. Hughes,et al.  B-108 Specific HIV integration sites are linked to clonal expansion and persistence of infected cells , 2016 .